TSC is thought to result from loss of function of hamartin or tuberin (encoded by TSC1 and TSC2, respectively), two tumor suppressors, normally acting in a complex to inactivate mammalian target of rapamycin complex 1 (mTORC1). The gene discussed is TSC2; the disease is neoplasm.